William Brian Dalton

12PUBLICATIONS
58CO-AUTHORS
Haematological tumoursMolecular targetsCancer cell biologyMedical virologyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 07, 2026
Outcome heterogeneity in CALR-mutated myeloproliferative neoplasms.

|Aug 03, 2026
Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction.

|Feb 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for BCR-ABL B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation.

John Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur

|Oct 07, 2025
Distinct and convergent effects of SF3B1 mutations in human breast cancer.

Riley E Bergman, Christin I Keeton, Irika R Sinha

|Jun 04, 2025
Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML.

Ilias Sinanidis, Panagiotis Tsakiroglou, Benjamin Dubner

|Dec 03, 2024
Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1- mutant cholangiocarcinoma.

Daniel J Zabransky, Emma Kartalia, Jae W Lee

Pageof 2

Frequent Collaborators

5 joint publications

Tania Jain

4 joint publications

Gabriel Ghiaur

4 joint publications

Jonathan Webster

3 joint publications

Theodoros Karantanos